AU6589494A - Method and compositions for disrupting the epithelial barrier function - Google Patents

Method and compositions for disrupting the epithelial barrier function

Info

Publication number
AU6589494A
AU6589494A AU65894/94A AU6589494A AU6589494A AU 6589494 A AU6589494 A AU 6589494A AU 65894/94 A AU65894/94 A AU 65894/94A AU 6589494 A AU6589494 A AU 6589494A AU 6589494 A AU6589494 A AU 6589494A
Authority
AU
Australia
Prior art keywords
disrupting
compositions
barrier function
epithelial barrier
epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65894/94A
Other languages
English (en)
Inventor
Peter M. Elias
Kenneth R Feingold
Walter M. Holleran
Carl R Thornfeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Adamis Pharmaceuticals Corp
Original Assignee
University of California
Cellegy Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Cellegy Pharmaceuticals Inc filed Critical University of California
Publication of AU6589494A publication Critical patent/AU6589494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AU65894/94A 1993-03-19 1994-03-21 Method and compositions for disrupting the epithelial barrier function Abandoned AU6589494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3380793A 1993-03-19 1993-03-19
US033807 1993-03-19
PCT/US1994/003030 WO1994021230A1 (en) 1993-03-19 1994-03-21 Method and compositions for disrupting the epithelial barrier function

Publications (1)

Publication Number Publication Date
AU6589494A true AU6589494A (en) 1994-10-11

Family

ID=21872550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65894/94A Abandoned AU6589494A (en) 1993-03-19 1994-03-21 Method and compositions for disrupting the epithelial barrier function

Country Status (3)

Country Link
AU (1) AU6589494A (he)
IL (1) IL109037A (he)
WO (1) WO1994021230A1 (he)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
JPH10506531A (ja) * 1994-09-19 1998-06-30 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー マラリア病の治療
US5863716A (en) * 1994-09-19 1999-01-26 The Leland Stanford Junior University Board Of Trustees Treatment of plasmodium
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
AU4919397A (en) * 1996-10-23 1998-05-15 Cellegy Pharmaceuticals, Inc. Method and compositions for disrupting the epithelial barrier function
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
USRE37770E1 (en) 1997-01-24 2002-06-25 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060515A (en) * 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
US6060043A (en) * 1998-02-03 2000-05-09 The Gillette Company Deodorant composition containing D-amino acid
WO2000066105A2 (en) * 1999-04-30 2000-11-09 The Trustees Of Boston College Treatment of epilepsy with imino sugars
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
KR100764699B1 (ko) * 2000-09-08 2007-10-08 알자 코포레이션 경로 폐쇄 저해에 의한 경피 약물 플럭스 감소 저해방법
DE10214506A1 (de) * 2002-04-02 2003-10-16 Beiersdorf Ag Verwendung von Desoxynojirimycin und dessen Derivaten zur Behandlung und Prophylaxe degenerativer Hautzustände

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition

Also Published As

Publication number Publication date
WO1994021230A1 (en) 1994-09-29
IL109037A0 (en) 1994-06-24
IL109037A (he) 1999-01-26

Similar Documents

Publication Publication Date Title
AU6620794A (en) Fire barrier
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU5208393A (en) Barrier coating
AU5794094A (en) Tricritical point composition
AU7961094A (en) Picosulphate dosage form
AU4478293A (en) Improved doorstop
AU6589494A (en) Method and compositions for disrupting the epithelial barrier function
AU7220794A (en) Detergent-package combination
AU7437094A (en) Disinfectant-detergent composition
IL109036A0 (en) Method and compositions for disrupting the epithelial barrier function
AU5773994A (en) Cable-making compositions
AU4919397A (en) Method and compositions for disrupting the epithelial barrier function
AU6774694A (en) Taste-masking pharmaceutical compositions and methods for making the same
AU672124B2 (en) Composition
AU1274295A (en) Heteroarylpyrroles
AU8098394A (en) Barrier coatings for surfaces
AU6078294A (en) Building block
AU6683494A (en) Barrier
AU6261194A (en) Fire barrier composition
AU3747297A (en) Termite barrier
EP0764017A4 (en) METHODS AND COMPOSITIONS FOR INDUCING PHASE SEPARATION IN DUAL EPITHELIAL LIPID LAYERS
AU7502394A (en) Improved fire barrier
AU4373193A (en) Polymer compositions
AU3696093A (en) Aquamate